MOCA Living Well: Understanding PARP Inhibitors in Ovarian Cancer
Thursday, March 8, 2018 - 6:30 pm - 8:00 pm
2180 North Hamline Ave
Roseville, Minnesota 55113
Recently, the approval of several PARP Inhibitors for ovarian cancer treatment and maintenance therapy has ushered in new options for women with ovarian cancer. And while these are exciting developments, these treatments bring with them new questions.
At our next MOCA Living Well meeting, we’ll hear from Mayo Clinic’s Dr. Andrea Wahner Hendrickson and learn more about these treatments. Find out how they’re used, how they differ from each other, who may benefit and other important information ovarian cancer survivors should know about PARP Inhibitor treatments.
You’ll be able to ask questions of Dr. Wahner Hendrickson and connect with other survivors.
The meeting is free and open to the public, but your RSVP is requested.